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Abstract 
 
Clinical studies have established aldosterone as a critical physiological and 
pathophysiological factor in salt and water homeostasis, blood pressure control and in 
heart failure. Genetic and physiological studies of mice are used to model these 
processes. A sensitive and specific assay for aldosterone is therefore needed to monitor 
adrenocortical activity in murine studies of renal function and cardiovascular diseases.  
Methods: Antibodies against aldosterone were raised in sheep as previously described. 
HRP-Donkey-anti-sheep IgG enzyme tracer was produced in our laboratory using the 
Lightning-Link HRP technique. Aldosterone ELISA protocol was validated and 
optimised to achieve the best sensitivity. Cross reactivity with likely competing steroids 
and specificity before and after chromatography were checked.. The assay was validated 
by analysing the urine of mice collected under various experimental conditions designed 
to stimulate or suppress aldosterone in the presence of other potentially interfering steroid 
hormones. 
 Results: Cross-reactivity with major interfering steroids was minimal: 
corticosterone=0.0028%, cortisol=0.0006%, DOC=0.0048% except for 5α-dihydro-
aldosterone=1.65%. Minimum detection limit of this ELISA was 5.7 pmol/L (1.6 
pg/mL). The validity of urinary aldosterone ELISA was confirmed by the excellent 
correlation between the results obtained before and after solvent extraction and HPLC 
separation step (Y=1.048X+0.006, R2=0.998, n=42). Accuracy studies, parallelism and 
imprecision data were determined and all found to be satisfactory. Using this assay, mean 
urinary aldosterone levels were (i) approximately 60 fold higher in females than males; 
(ii) increased 6 fold by dietary sodium restriction; (iii) increased x fold by ACTH 
infusion; (iv) reduced by >60% in Cyp11b1 null mice. 
Conclusion We describe an ELISA for urinary aldosterone which is suitable for repeated 
non-invasive measurements in mice. Female aldosterone levels are higher than males. 
Unlike humans, most aldosterone in mouse urine is not conjugated. Increased levels were 
noted in response to dietary sodium restriction and ACTH treatment. The sensitivity of 
the assay is sufficient to detect suppressed levels in mouse models of congenital adrenal 
hyperplasia.. 
.  
 
Introduction 
 
Mice are very widely used to study cardiovascular disease. Many genetically modified 
strains have become available which target all aspects of disease processes including 
those related to the renin-angiotensin-aldosterone system (Mullins et al). However, a 
major problem with mice is the limitation of blood volume particularly for repeated 
measures of analytes which circulate at low concentrations. Also there is the likelihood of 
introducing stress artefacts when sampling blood in small rodents. These problems are 
exacerbated for aldosterone where assays must specifically exclude competing steroids 
such as corticosterone which circulate at 500- 1000 fold greater concentrations. 
Limitations of volume and stress associated with blood sampling can be avoided by 
analysing 24h urine samples but there is a clear need for a simple, sensitive and specific 
method of quantifying aldosterone secretory activity.  
 2
The majority of immunoassays use 3H or 125I labelled tracer d to measure aldosterone 
levels [1-7]. Although sensitive, the radioactivity is a biohazard and waste disposal is 
costly and inconvenient. Some non-isotopic assays have been reported [9-16] but reliable 
and sensitive commercial assays for aldosterone are not widely available and none have 
been validated for mice. Here we describe an elisa method for the measurement of 
aldosterone in mouse urine which has the specificity and sensitivity to detect changes in 
secretory activity in response to pathophysiological conditions of ACTH excess and 
congenital adrenal hyperplasia as well as physiological differences between males and 
females and in response to a low sodium diet. 
 
 
Materials and Methodology 
 
Assay reagents 
Anti-aldosterone antibodies were raised in sheep as previously described [5-7] and used 
at a final dilution of 1:100,000. HRP-Donkey-anti-sheep IgG enzyme conjugate was 
produced in our laboratory using the Lightning-Link HRP technique following the 
instructions outlined in the manufacturer’s manual (Innova Biosciences, Cambridge) and 
used to develop the ELISA method at a dilution of 1:2000. 
 
Aldosterone standard was purchased from Sigma-Aldrich, Poole, Dorset, England. All 
other steroid hormones used for cross-reactivity studies (see Table 1) were obtained from 
Sigma-Aldrich, Poole, Dorset, UK and Steraloids, Newport, RI, USA. Other reagents: 
ELISA plates were purchased from Dynex, USA or Griener Bio-One, Germany. β-
glucuronidase (from Helix pomatia), Tween 20, sulphuric acid, tetra-methyl-benzidine 
(TMB), hydrogen peroxide (30%) and bovine serum albumin were all obtained from 
Sigma-Aldrich. Quick-fit glass extraction tubes from Bibby Sterilin Ltd, Staffs, UK 
Dichloromethane (Analytical grade) and methanol (HPLC grade) were obtained from 
Fischer Scientific, Leicester, UK. 
 
Solvents and Solutions 
Assay buffer: 0.05 mole/L Phosphate Buffer Saline (PBS) pH 7.4 containing 0.1% 
Bovine Serum Albumin (BSA). Blocking Buffer: 0.025 mole/L PBS pH 7.4 containing 
0.5% BSA. Coating buffer 0.025 mole/L PBS pH 7.4. Wash buffer: 0.015 mole/L PBS 
pH 7.4 containing 0.05% Tween 20. Substrate buffer: 0.2 mole/L Acetate/Citrate buffer 
pH 4.2. Stop solution: 1 mole/L Sulphuric acid in distilled water. Aldosterone-BSA 
conjugate purchased from Steraloids, USA dissolved in coating buffer.  
 
Various dilutions of sheep anti-aldosterone were prepared in assay buffer and tested by 
the ELISA method and an initial dilution of 1:100,000 was found to produce satisfactory 
signal. Horse Radish Peroxidase-Anti-sheep IgG conjugate solution was prepared in 
assay buffer and tested at several dilutions and the optimal dilution was found to be 
1:2000 of the original conjugate preparation. Substrate solution containing 10mg/mL of 
TMB in Acetate/citrate buffer pH 4.2 was found to produce maximum colour signal. 
Standard aldosterone solutions were prepared freshly in assay buffer from a stock 
aldosterone solution of 1μM in assay buffer.  
 
 
Urine samples 
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Urine samples were collected daily from mice held singly in metabolic cages (Tecniplast, 
Italy) and stored in universal containers without preservatives at -20°C until required for 
assay. All animals were adapted to the cages for a minimum 4 days before starting urine 
collections and were given free access to food and water in a light and temperature 
controlled room. Unless otherwise stated, mice were adult C57Bl6 (Harlan Olac) fed a 
diet containing 0.3% sodium (SDS Ltd, Witham, Essex). To test the effects of sodium 
restriction, urinary aldosterone was measured during adaptation to a diet containing 
0.03% sodium. Data showing urinary aldosterone values during ACTH infusion (125ng 
Synacthen / h) and in Cyp11b1 null mice are from studies which are described elsewhere.  
 
Hydrolysis and extraction protocol of urine samples  
Steroids in 0.5ml urine were extracted into organic solvent by vortexing with 10 mL 
dichloromethane in glass-stoppered tubes and the extract washed successively with 1 mL 
aliquots of 0.05M NaOH, 0.05M HCl and distilled water. The solvent was then 
evaporated at 40oC and the residue reconstituted in 1mL assay buffer. Extraction 
recovery was checked in 20 urine samples by using 3H-Aldosterone (Amersham) and 
found to be 95.2 % ± 5.6 (SD); results were not corrected for recovery. Steroid 
conjugates in urine (0.5ml) were hydrolysed by incubating with 0.5ml β-glucuronidase 
solution (Helix Pomatia 10,000 units/ml in 0.5 M acetate buffer pH 5.5) at 37oC for 18-
24h. Aldosterone values were not signifantly affected by hydrolysis. 
 
Optimisation of Assay protocol for the Urinary aldosterone ELISA 
Aldosterone was measured using an indirect ELISA technique. with some modifications 
to sensitise the assay [27-29]. The ELISA standard curve was optimised for the amount 
of conjugate needed to coat the plate, time and temperature of incubation and the dilution 
of aldosterone antibody required. All samples were assayed in duplicate. 96 well ELISA 
plates were coated with aldosterone-3-CMO-BSA conjugate (200μL coating buffer 
containing 0.2 µg conjugate/mL). The plates were then covered with film and left 
overnight at 4oC. The coating solution was discarded, plates were washed four times with 
250 μl wash buffer and then blocked by incubating with 200 μl blocking buffer for 1h at 
37°C.. The blocking buffer was discarded and plates were blotted and left to dry in air. 
Aldosterone standards (0-100 nM) and urine extracts (50μl in duplicate) were added to 
the wells followed by 100 μl of antibody solution. After incubation at room temperature 
for two hours, the contents were discarded and the plate washed with buffer as before. At 
this point 100 μl of HRP-anti-sheep enzyme conjugate was added to each well and the 
plates incubated at room temperature for another hour. Plates were emptied and washed 
before adding 100ul substrate solution. Finally, after a 15minute incubation at room 
temperature, 50 μl of stop solution was added and absorbance was read at 450nm in an 
MRX plate reader. 
 
Calculation of results 
Aldosterone concentration in the sample was calculated by using the semi-log cubic 
spline software data reduction method built in to the MRX ELISA reader. After taking 
account of urine volume and body weight, values are then expressed as pmol/day/g body 
weight ± SE. 
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HPLC system procedure  
Specificity was checked by comparing results with and without HPLC separation. 
Dicholoromethane extracts of 42 urine samples were divided into two aliquots. Both 
aliquots were evaporated to dryness, one was reconstituted in assay buffer and assayed 
directly for aldosterone and the other was reconstituted in HPLC mobile 
phase.(water:isopropanol, 87:13, v/v). Samples were fractionated using a Dionex HPLC 
system with a reverse phase Sunfire C18 15cm-column at a temperature of 35C , a flow 
rate of 1ml/min and with a mobile phase containing stepped increases in the proportion of 
isopropanol in the mobile phase (13% x 6 min, 15% x 16 min; 21% x 8 min; 28% x 8 
min; 39% x 6min).  Retention times of 9.9, 20.4, 28.9 and 36.6 minutes for authentic 
aldosterone, corticosterone, deoxycorticosterone and progesterone standards were noted 
by monitoring eluate at 245nm. Corresponding fractions for urine samples were 
collected, dried down. and reconstituted in ELISA assay buffer.  
 
Validation of aldosterone ELISA 
Cross-reactivity of various steroid hormones with the aldosterone antibody using the 
optimised ELISA standard curve was determined according to the methods of Abraham 
[32]. Validation procedures were carried out as previously published [27,28]. Accuracy 
was determined by adding known amounts of standard aldosterone (0.05 - 10.0 nmol/L) 
to urine samples. All samples (spiked and non-spiked urine) were assayed by aldosterone 
ELISA. The amount of aldosterone recovered was then calculated by subtracting the 
spiked dose from the value obtained for each spiked urine sample. Imprecision was 
estimated by replicate determinations of aldosterone levels in low, medium and high 
pools measured in the same (intra-) or different (inter-) assays over a period of 20 weeks. 
Blank values of the aldosterone ELISA were checked by using distilled water instead of 
the urine sample and the results were not statistically different from the zero standard  
blank of the ELISA reader (0.042± 0.015). To test for parallelism and the effect of 
varying urine osmolality on the assay, serial dilutions of 4 urine samples taken from 
different animals were made in distilled water and the dilutions were extracted and 
treated as described above, then assayed. 
 
Correlation studies  
 
Various urine samples obtained from several animals were assayed for urinary 
aldosterone excretion after enzyme hydrolysis and solvent extraction by the ELISA 
method and by an in-house RIA method (n=33).  To further verify the results of the 
aldosterone ELISA, 42 urine samples were also assayed before and after an HPLC 
separation step as described above. Linear regression analysis was used throughout to 
compare the results obtained by different methods. 
 
Results 
 
Optimisation of aldosterone standard curve The effect of varying the amount of 
aldosterone-BSA conjugate on the standard curve is shown in figure 1. Typical standard 
curve data for aldosterone ELISA are shown in Figure 2. Sensitivity (minimum detection 
limit) for the aldosterone ELISA standard curve was determined according to the method 
of Abraham [33]. The amount of aldosterone that produced a statistically significant drop 
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in signal compared with that of the zero standard was found to be 5.2 pM or 1.5 pg/mL or 
75fg/well. When the limits of detection (LOD) was determined according to IUPAC as 
the mass of analyte required to decrease the signal of zero standard by 2 SD [30], the 
sensitivity was 12.5 pmole/L or 3.6 pg/mL or 180fg/well.  
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Figure 1. Effect of varying the amount of aldosterone conjugate used to 
coat the plate on the ELISA standard curve. Values range from 10μL to 
80μL/mL (0.2-1.6 μg/mL) of conjugate solution. 
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Figure 2, Typical aldosterone ELISA standard curve (mean ± 
SE; n = 16).  
 
Validation of aldosterone ELISA 
Cross-reactivity of aldosterone antibody with major interfering steroids was minimal 
except for 5α-Dihydroaldosterone =1.65% (see Table 1). Accuracy studies, parallelism 
and imprecision data were determined and all found to be satisfactory. The accuracy of 
aldosterone ELISA is shown in Table 2 (recovery of added aldosterone ranged from 98.2-
106.1% with a mean of 100.6% ±3.66). The results of serial dilution of 4 urine samples 
were shown in Table 3 (%CV for calculated results ranged from 2.2-3.5%). The results of 
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intra-assay and inter-assay imprecision for 3 urine pools ranged from 5.12- 8.74% CV 
and 5.78- 10.07% CV respectively (see Table 4).  
  
 
 
 
 
Table 1: Cross-reactivity data for the sheep aldosterone antibody 
used in the ELISA 
Steroid % Cross Reactivity 
Aldosterone    100.00 
5β-Dihydroaldosterone         0.045 
5α-Dihydroaldosterone         1.65 
Tetra hydroaldosterone         0.0018 
Corticosterone         0.0028 
Deoxycorticosterone         0.0048 
Cortisol         0.0006 
11-Deoxycortisol         0.0001 
Progesterone         0.0011 
17 α -OH-progesterone         0.0007 
18-OH-Deoxycorticosterone          0.002 
18-OH-corticosterone         0.0006 
20α -OH-progesterone         0.0003 
Tetrahydrodeoxycorticosterone         0.0002 
5 β –Tetrahydrocorticosterone      < 0.0001 
5 α -Dihydrocorticosterone         0.0007 
5 β –Dihydrocortisol      < 0.0001 
5 α –Dihydropregnenolone         0.0008 
Testosterone         0.0006  
Androstenedione      < 0.0001  
Dehydroepiandrosterone      < 0.0001 
Cholesterol      < 0.0001 
Estrone      < 0.0001 
Estradiol-17 β       < 0.0001 
Estriol      < 0.0001 
 
 
Table 2, Accuracy data obtained by the aldosterone urine ELISA. Percent recovery 
of aldosterone standard added to urine samples (n = 9).  
 
Amount added (nmole/L) Mean Amount recovered 
(nmole/L) 
% Mean Recovery 
0.05 0.0512 102.4 
0.10 0.106 106.1 
1.25 1.23 (n= 9)  98.2 
2.5 2.48 (n= 9)  99.4 
10.0 9.7 (n= 9)  97.0 
Overall Mean ±1SD   100.6 ±3.7 
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Table 3, Results of urinary aldosterone samples obtained by the serial dilution of 4 
urine samples. 
 
Sample No.  1 2 3 4 
Mouse genotype Wild (+/+) Wild (+/+) KO (-/-) KO (-/-) 
Calculated value (nmole/day) (nmole/day) (nmole/day) (nmole/day) 
Neat Value 9.878   12.576  0.426 0.886 
Dilution factor     
X2  9.824  12.724   0.432  0.912 
X4 10.112  12.048   0.456  0.856 
X8 10.224  12.516    0.466  0.924 
X16  9.685  12.192   0.446 
 
 0.934 
Mean 9.9446 12.5596   0.4492  0.9024 
±1SD 0.219351 0.296082   0.019005  0.03154 
% C.V. 2.20% 2.36%  4.23  3.5 
 
 
Table 4, Imprecision data for the urinary aldosterone  ELISA. 
a) Intra-assay imprecision   
Aldosterone 
Mean (nmole/day) 
± 1SD %C.V. 
(Coefficient of Variation) 
24.944 1.277 5.12 
1.722 0.128 7.43 
0.286 0.025 8.74 
 
        b) Inter-assay imprecision 
Aldosterone 
Mean (nmole/day) 
± 1SD %C.V. 
(Coefficient of Variation) 
24.689 1.428 5.78 
1.756 0.135 7.69 
0.288 0.029 10.07 
 
 
 
 
Comparison with RIA and the effects of HPLC 
Comparison of the results by the present ELISA with those estimated by the in-house 
RIA method is shown in Fig. 3 (ELISA= 0.657RIA – 44.418, R2 = 0.897, p<0.001, n = 
33). The values obtained by the aldosterone ELISA were 20-35% lower than those 
measured by the RIA.  
To confirm the specificity of the assay, results were compared with and without HPLC 
separation. There was an excellent correlation between the two sets of values (figure 4) 
non HPLC= 1.046(HPLC values) + 0.0026, r2 = 0.998, p<0.001, n= 42  
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y = 0.6572x - 44.418
R2 = 0.8923
0
200
400
600
800
1000
1200
1400
1600
1800
0 500 1000 1500 2000 2500
Aldosterone RIA (pmol/L)
A
ld
os
te
ro
ne
 E
LI
SA
 (p
m
ol
/L
)
 Figure 3, Comparison of urinary aldosterone results obtained by the 
new ELISA with those of the radioimmunoassay. 
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Figure 4, Comparison of urinary aldosterone results before and after 
HPLC fractionation. 
 
 
Urinary aldosterone animal data 
 
Figure 5 shows aldosterone levels in normal male and female mice and in a mouse model 
of congenital adrenal hyperplasia. Female mice levels were approximately 60 fold higher 
than those of male mice. Urinary aldosterone values in Cyp11b1 null mice were 60-80% 
lower than wild type controls. Cyp11 b1 null mice have suppressed aldosterone values  
because they secrete 25-65 times higher amounts of deoxycorticosterone; an alternative 
mineralocorticoid. 
Figure 6 shows the effects of dietary sodium restriction Urinary aldosterone of normal 
male type mice increased more than 6 fold over the first 4 days of adaptation from a 
normal (0.3% NaCl) to a low sodium (0.03% NaCl) diet. 
Figure 7 shows the infusing ACTH in normal mice on urinary aldosterone values. 
Aldosterone is markedly increased during the first few days of infusion but reduces to 
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near pre-infusion levels during the second week. In contrast, corticosterone values which 
are also stimulated >100 fold by ACTH (data not shown) are higher in the second week 
than the first week. This highlights the fact that even under pathophysiological 
conditions, excessively high glucocorticoid values do not interfere in the measurement of 
aldosterone. 
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Figure 5: Aldosterone daily urinary excretion in male and female 
animals. Wild type (+/+); Cyp11b1 knockout mice (-/-) (data from 
Mullins et al, JBC in press) 
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Figure 6: Effect of low sodium diet and adaptation on urinary 
aldosterone excretion in male mice as measured by the present ELISA. 
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Figure 7 Effect of Synacthen infusion (3μg/d) via Alzet mini-osmotic 
infusion pumps on urinary aldosterone excretion in male mice (n=5, ± 
sem). (data are from unpublished work of Dunbar et al) 
 
Discussion and Conclusion 
A highly sensitive, specific and easy to perform ELISA has been developed and 
validated for the measurement of aldosterone in mouse urine samples. Estimation of 24 
hour urinary aldosterone values represents the ideal medium to investigate the 
physiology and pathophysiology of mouse models in which adrenocortical function is 
affected. It is impractical to collect repeated blood samples from these animals because 
blood volume is too small to permit sampling at more than one time point and because 
there are risks of introducing artefacts from stress associated with handling the animal 
or from anaesthesia used to collect un-stressed samples. We have established that the 
assay is sufficiently sensitive to identify normally low levels of aldosterone and even 
abnormally low levels when secretion is suppressed. The specificity of the assay has 
been confirmed by in vitro crossreactivity tests and by demonstrating appropriate 
responses to a variety of physiological and pathophysiological tests. 
Specificity is a particular problem when measuring urinary aldosterone firstly because it 
circulates at much lower concentrations than other corticosteroid hormones with similar 
chemical structures and, secondly, because urine contains relatively high levels of 
aldosterone metabolites. In vitro tests confirmed that the antibody discriminated 
aldosterone from other likely competitors. Only dihydroaldosterone came close to being 
a problem. Previous studies have found erroneously high values for aldosterone when 
antibodies with greater affinity for this reduced metabolite were used but not with a 
different antibody with lesser affinity. It is notable that the specifity of this alternative 
successful antibody was less than the one used in the present ELISA. Using samples 
with a wide range of aldosterone concentrations, we have shown that values measured 
before and after HPLC fractionation are in agreement. We have also tested the assay 
with samples collected from mice treated longterm with an infusion of ACTH. This 
treatment exaggerated the normal disparity between corticosterone and aldosterone yet 
we were able to demonstrate the transient and much lower increase in urinary 
aldosterone despite sustained high corticosterone levels.  
Although ACTH is an established modulator of aldosterone secretion, the primary 
regulators are circulating angiotensin II and potassium concentrations. Dietary sodium 
controls renin-angiotensin which regulates aldosterone secretion to maintain salt and 
water homeostasis (Williams 2004). We therefore measured urinary aldosterone during 
adaptation to low sodium food as a test of the assay’s ability to detect physiologically 
relevant changes. The results show an aldosterone response to switching from a 0.3 to a 
0.03% sodium after 1 day reaching a maximal 6 fold increase after three days. 
Furthermore we found that under normal dietary conditions, female urine has 60-fold 
higher concentrations than that of males. In part this also reflects higher circulating 
levels of the renin-angiotensin system. However, it is also known that the female 
adrenal gland is larger than that of males and that the renin-angiotensin-aldosterone 
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system is different in male and female rodents (Deschepper et al, Inagami ). In 
particular, Morris and colleagues (  )have demonstrated that following an injection of 
aldosterone, the clearance rates of aldosterone and the nature of urinary and fecal 
aldosterone metabolites is different in males and females.  
Due to the use of highly specific antibodies and careful optimization of the amount of 
steroid conjugate adsorbed onto the plates, the new ELISA was sensitive enough to 
detect abnormally low levels. In Cyp11b1 null mice, adrenal 11β hydroxylase activity 
(the final enzyme the synthesis of glucocorticoid hormones) is deficient. This leads to an 
accumulation of a steroid substrate, deoxycorticosterone with mineralocorticoid 
properties that suppress the renin-angiotensin sytem. Using the present Elisa we showed 
that urinary aldosterone was suppressed by 60-80% in male and female samples from 
homozygous Cyp11b1 null mice when urinary deoxycorticosterone was increased 30-60 
fold. Our expectation is that this assay will be particularly useful in phenotyping other 
pathophysiological models of low aldosterone (eg 11hsd2 null mice) as well as 
adaptation to high sodium diet. 
 
The assay has been validated for accuracy, parallelism (dilution of urine samples) and 
imprecision with samples from wild type, heterozygote and cyp11B1 null mice. The 
results obtained were found to be very satisfactory. Furthermore, the validity of the 
aldosterone urinary ELISA was confirmed by the excellent correlation between the 
results obtained by the assay before and after an HPLC fractionation step. The results of 
the ELISA correlate well with our in-house RIA methods using tritiated-aldosterone 
label. However values by the new ELISA were (20-35%) lower than those by RIA. This 
is probably due to the 3H-aldosterone tracer that has previously been shown to produce 
inferior specificity and imprecision data [7]. The ELISA is at least as fast as RIA and 
obviates the need for expensive and hazardous radioactive tracer thereby reducing the 
costs of raw materials and their disposal. The assay is ideal for use in large projects 
involving huge number of samples. 
In humans, aldosterone is mainly excreted as a glucuronide in urine (Mohring et al, Tait 
et al) and thus estimation of total aldosterone is usually done after hydrolysis of the 
conjugate [25, 26]. We have used the enzymatic hydrolysis method (β-glucuronidase, 
Helix pomatia, Sigma) as optimised by Ferchaud et al [25, 35] to pre-treat mouse urine. 
Although values of other adrenocorticosteroids (eg deoxycorticosterone) were 
increased by hydrolysis particularly in female samples, aldosterone values were not 
signifantly affected. This would suggest that prior to glucuoronidation, aldosterone is 
metabolised to a compound which is not recognised by the ELISA and, possibly, that 
the renal enzyme responsible for the production human urinary aldosterone glucuronide 
may not necessarily be expressed in mouse kidney. 
 
In conclusion, a simple and highly sensitive ELISA has been developed to estimate 
urinary excretion of aldosterone. The assay can identify physiological responses to 
dietary sodium intake in mice and has demonstrated differences in male and female 
values. The assay has also demonstrated its usefulness in analysing high and low levels 
in pathophsiological states of excess ACTH and congenital adrenal hyperplasia.f 
 
 
List of Abbreviations 
BSA = Bovine Serum Albumin 
         ELISA = Enzyme linked immunosorbant assay 
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         C.V. = Coefficient of variation 
         CYP11b1 = Gene encoding 11 β-Hydroxylase enzyme 
         GC/MS = Gas Chromatography/Mass Spectrometry 
         HPLC = High Performance Liquid Chromatography 
         HRP = Horse Radish Peroxidase 
         IgG = Immunoglobulin 
         LOD = Limit of Detection 
         PBS =  Phosphate Buffered saline 
         RIA = Radioimmunoassay 
         SD =  Standard deviation 
         TMB = Tetra-Methyl Benzidine 
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